Keywords: crucell, signs, cross-licensing, deal, merck, co, dutch

Crucell signs cross-licensing deal with Merck & Co

Article | 08 January 2007

Dutch biotechnology company Crucell NV has signed a cross-licensing agreement with US drug major Merck & Co. In addition to previously-licensed ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in

Related Companies

Merck

Merck KGaA

Go to company listing